Conference abstract · 15 Oct 2013
Conference abstractPublished 15 Oct 2013
Understanding the essential requirements for success in structure-based design
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We know that for any prediction the quality of the data used to build a model has a direct impact on the quality of the predictions from that model. Developing and validating software for modeling protein-ligand interactions requires protein-ligand structure data; developing and validating high quality software for modeling protein-ligand interactions therefore requires high quality structure data. If predictions from a molecular docking program fail, is the failure the result of poorly developed software, using poor data for the prediction, or the use of poor data invalidation? This presentation will discuss methods to measure the suitability of protein-ligand structure data for docking software validation. Using the recently published iridium data set, it will be shown that a high proportion of structures used for validating docking software in the past are, in fact, entirely unsuitable for this task, but heuristics will be presented that will allow assembly of datasets appropriate for this purpose.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 7 Jun 2017
Structure-based design of subtype selective antagonists for the ionotropic glutamate receptors: Successes and failures
Short communication · 29 Apr 2025
Structure-based Design of Small Molecule Inhibitors Targeting SARS-CoV-2 Proteins
Conference abstract · 15 Oct 2013
GPCR-ModSim-A Computational Platform for the structure-based drug design of GPCRs and applications to the design of potent and selective adenosine receptor antagonists
Commentary · 29 Dec 2025
Structure-Based Drug Design: From Targets to Therapeutics
More from this journal
The newest in Medicinal Chemistry.
Brief report · 30 Jun 2026
Covalent Drugs in Medicinal Chemistry: Emerging Opportunities and Ongoing Challenges
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Gregory L. Warren”

